Immunodeficiency and new treatment for HBV.
Benhamou
Y
Y
D000998:Antiviral Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine; D016047:Zalcitabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000998:Antiviral Agents; D019259:Lamivudine; D016047:Zalcitabine